CAPG and CAPN1 were found to be overexpressed in advanced stages of BRCA1-mutant ovarian cancers while PFN1, CFN1, and 14-3-3 were shown to be downregulated. This evidence concerns the gene BRCA1 and ovarian carcinoma.